Healthcare -
Biotechnology - NASDAQ - US
$ 38.6444
-0.118 %
$ 10.8 B
Market Cap
21.96
P/E
EXEL - RESEARCH & DEVELOPMENT
Research & Development EXEL - Exelixis, Inc.
910 M
LAST VALUE
1.04%
2 YEAR CAGR
21.99%
5 YEAR CAGR
17.02%
10 YEAR CAGR